CHELMSFORD, Mass., Oct. 16, 2020 /PRNewswire/ -- Brooks
Automation, Inc. (Nasdaq: BRKS) announced today that Dr.
Amy Liao, president of Brooks Life
Science Services, has received the Biomedical Engineering Society's
Wallace A. Coulter award for
innovation in healthcare. The Coulter award recognizes an
outstanding individual who has demonstrated a lifetime commitment
to and made important contributions to patient healthcare.
Dr. Liao will be speaking at the plenary session of the 2020
Biomedical Engineering Society's virtual meeting on Friday October 16, 2020.
"We are very proud to see Amy recognized by the Biomedical
Engineering Society with this award," commented Steve Schwartz, CEO and president of Brooks
Automation. "Amy's accomplishments with over 20 years in the
field of genomics has led to breakthrough innovations in gene
sequencing and gene synthesis, and in GENEWIZ, she built a company
that has supported thousands of customers in their pursuit of
scientific discoveries. All of us at Brooks congratulate Amy
for this recognition of her achievements."
Dr. Amy Liao was appointed
President of Brooks Life Sciences Services in April 2020. She
joined Brooks in November 2018
following its acquisition of GENEWIZ, a global provider of genomics
services, which she co-founded in 1999. Dr. Liao held various
leadership positions during her tenure at GENEWIZ culminating in
her appointment as Chief Executive Officer in January 2017.
Dr. Liao received her Ph.D. in Biochemistry and Cell Biology from
SUNY Stony Brook. She did her post doctorate studies at
Columbia University before leaving to
found GENEWIZ. She holds a B.S. in Biochemistry from Nankai
University, China and an M.S. in
Biochemistry from Tsinghua University, China.
About Brooks Automation
Brooks (Nasdaq: BRKS) is a
leading provider of life science sample-based solutions and
semiconductor manufacturing solutions worldwide. The
Company's Life Sciences business provides a full suite of reliable
cold-chain sample management solutions and genomic services across
areas such as drug development, clinical research and advanced cell
therapies for the industry's top pharmaceutical, biotech, academic
and healthcare institutions globally. Brooks Life Sciences'
GENEWIZ division is a leading provider of DNA gene sequencing and
gene synthesis services. With over 40 years as a partner to
the semiconductor manufacturing industry, Brooks is a provider of
industry-leading precision vacuum robotics, integrated automation
systems and contamination control solutions to the world's leading
semiconductor chip makers and equipment manufacturers. Brooks
is headquartered in Chelmsford,
MA, with operations in North
America, Europe and
Asia. For more information, visit www.brooks.com.
INVESTOR and MEDIA CONTACT:
Mark Namaroff
Director, Investor Relations
Brooks Automation
978.262.2635
mark.namaroff@brooks.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/dr-amy-liao-receives-the-wallace-a-coulter-award-for-healthcare-innovation-301153908.html
SOURCE Brooks Automation